Investigational EGFR 19delins NSCLC therapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Investigational EGFR 19delins NSCLC therapy, covering 2026-03-09 to 2026-03-09. Get the full timeline:
Most recent: Clinical Trial Update: Therapy for Advanced NSCLC With EGFR 19delins Mutation [EARLY_Phase 1]